| pubmed-article:9863868 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9863868 | lifeskim:mentions | umls-concept:C0019682 | lld:lifeskim |
| pubmed-article:9863868 | lifeskim:mentions | umls-concept:C0019693 | lld:lifeskim |
| pubmed-article:9863868 | lifeskim:mentions | umls-concept:C0019699 | lld:lifeskim |
| pubmed-article:9863868 | lifeskim:mentions | umls-concept:C1257890 | lld:lifeskim |
| pubmed-article:9863868 | lifeskim:mentions | umls-concept:C0009247 | lld:lifeskim |
| pubmed-article:9863868 | lifeskim:mentions | umls-concept:C0035171 | lld:lifeskim |
| pubmed-article:9863868 | lifeskim:mentions | umls-concept:C0387687 | lld:lifeskim |
| pubmed-article:9863868 | lifeskim:mentions | umls-concept:C0242656 | lld:lifeskim |
| pubmed-article:9863868 | lifeskim:mentions | umls-concept:C0017260 | lld:lifeskim |
| pubmed-article:9863868 | lifeskim:mentions | umls-concept:C0750572 | lld:lifeskim |
| pubmed-article:9863868 | lifeskim:mentions | umls-concept:C1548673 | lld:lifeskim |
| pubmed-article:9863868 | pubmed:issue | 17 | lld:pubmed |
| pubmed-article:9863868 | pubmed:dateCreated | 1999-3-22 | lld:pubmed |
| pubmed-article:9863868 | pubmed:abstractText | To study the impact of the genotype CCR-5 wild-type +/A32 on the progression rate to AIDS and death, and to discuss sources of bias according to study design. | lld:pubmed |
| pubmed-article:9863868 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9863868 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9863868 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9863868 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9863868 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9863868 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:9863868 | pubmed:issn | 0269-9370 | lld:pubmed |
| pubmed-article:9863868 | pubmed:author | pubmed-author:GrindeBB | lld:pubmed |
| pubmed-article:9863868 | pubmed:author | pubmed-author:JonassenT OTO | lld:pubmed |
| pubmed-article:9863868 | pubmed:author | pubmed-author:EskildAA | lld:pubmed |
| pubmed-article:9863868 | pubmed:author | pubmed-author:SamuelsenS... | lld:pubmed |
| pubmed-article:9863868 | pubmed:author | pubmed-author:HegerBB | lld:pubmed |
| pubmed-article:9863868 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9863868 | pubmed:day | 3 | lld:pubmed |
| pubmed-article:9863868 | pubmed:volume | 12 | lld:pubmed |
| pubmed-article:9863868 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9863868 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9863868 | pubmed:pagination | 2271-4 | lld:pubmed |
| pubmed-article:9863868 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9863868 | pubmed:meshHeading | pubmed-meshheading:9863868-... | lld:pubmed |
| pubmed-article:9863868 | pubmed:meshHeading | pubmed-meshheading:9863868-... | lld:pubmed |
| pubmed-article:9863868 | pubmed:meshHeading | pubmed-meshheading:9863868-... | lld:pubmed |
| pubmed-article:9863868 | pubmed:meshHeading | pubmed-meshheading:9863868-... | lld:pubmed |
| pubmed-article:9863868 | pubmed:meshHeading | pubmed-meshheading:9863868-... | lld:pubmed |
| pubmed-article:9863868 | pubmed:meshHeading | pubmed-meshheading:9863868-... | lld:pubmed |
| pubmed-article:9863868 | pubmed:meshHeading | pubmed-meshheading:9863868-... | lld:pubmed |
| pubmed-article:9863868 | pubmed:meshHeading | pubmed-meshheading:9863868-... | lld:pubmed |
| pubmed-article:9863868 | pubmed:meshHeading | pubmed-meshheading:9863868-... | lld:pubmed |
| pubmed-article:9863868 | pubmed:meshHeading | pubmed-meshheading:9863868-... | lld:pubmed |
| pubmed-article:9863868 | pubmed:meshHeading | pubmed-meshheading:9863868-... | lld:pubmed |
| pubmed-article:9863868 | pubmed:meshHeading | pubmed-meshheading:9863868-... | lld:pubmed |
| pubmed-article:9863868 | pubmed:meshHeading | pubmed-meshheading:9863868-... | lld:pubmed |
| pubmed-article:9863868 | pubmed:meshHeading | pubmed-meshheading:9863868-... | lld:pubmed |
| pubmed-article:9863868 | pubmed:meshHeading | pubmed-meshheading:9863868-... | lld:pubmed |
| pubmed-article:9863868 | pubmed:meshHeading | pubmed-meshheading:9863868-... | lld:pubmed |
| pubmed-article:9863868 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9863868 | pubmed:articleTitle | The estimated impact of the CCR-5 delta32 gene deletion on HIV disease progression varies with study design. Oslo HIV Cohort Study Group. | lld:pubmed |
| pubmed-article:9863868 | pubmed:affiliation | Section of Epidemiology, National Institute of Public Health, Oslo, Norway. | lld:pubmed |
| pubmed-article:9863868 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9863868 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9863868 | lld:pubmed |
